Program

Posted on by BioNJ

 

Friday, October 4, 2013 

7:00 a.m. – 7:45 a.m. Registration and Networking Breakfast Buffet
7:45 a.m. – 8:00 a.m. Welcome
8:00 a.m. – 9:00 a.m. Panel – In the Trenches with Tranches: Financing Strategies for Growth
Lorenzo Pellegrini, Ph.D.
Partner
Care Capital, LLC

Stuart Peltz, Ph.D.
CEO
PTC Therapeutics, Inc.

Chris Tyrrell
CEO
OfferBoard

Michael Wells
Managing Director
Princeton Biopharma Capital Partners LLC

Moderator:
James Marino, Esq.
Partner
Dechert LLP

Introduced by:
Elizabeth Posillico, Ph.D.
President and CEO
Elysys Therapeutics, Inc.
9:00 a.m. – 9:15 a.m. Presenting Company
David Pearson, Ph.D.
President
Thrombogenics, Inc.

Introduced by:
John Maki
President and CEO
Vicus Therapeutics
9:15 a.m. – 10:00 a.m. Morning Keynote
Andre Wyss
US Country Head, President
Novartis Corporation and
President
Novartis Pharmaceuticals Corporation

Introduced by:
Jan Campbell
Senior Client Partner
Korn/Ferry International
10:00 a.m. – 10:25 a.m. Networking Break
10:25 a.m. – 10:40 a.m. Presenting Company
Will Lewis
President and CEO
Insmed Incorporated

Introduced by:
John Haney
Vice President, Immunology Marketing
Janssen Biotech
10:40 a.m. – 11:15 a.m. Morning Keynote
John F. Crowley
Chairman and CEO
Amicus Therapeutics, Inc.

Introduced by:
Pamela Demain, MBA, CLP
Executive Director, Corporate Licensing
Merck & Co., Inc.
11:15 a.m. – 12:15 p.m. Panel – Inside Outsourcing
John Barry
Global Head, Vendor Management for Development
Merck & Co., Inc.

Sally Macaluso
Vice President, Janssen R&D Procurement
Johnson & Johnson

Ralph Marcello
Principal
Deloitte

Raymond Hill
Presdient
inVentiv Health Clinical

John Watson
Corporate Senior Vice President, President, Strategic Partnering, and Chief Commercial Officer
Covance Inc.

Moderator:
John Fraher
President
Aptalis Pharma

Introduced by:
Donna Tempel, Ph.D.
President and CEO
Drais Pharmaceuticals Inc.
12:20 p.m. – 12:50 p.m. Lunch
12:50 p.m. – 1:35 p.m. Luncheon Keynote
Robert J. Hugin
Chairman and CEO
Celgene Corporation

Introduced by:
Shawn Tomasello
Corporate VP and General Manager, US Hematology and Oncology
Celgene Corporation
1:40 p.m. – 2:40 p.m. Panel – How Wide is the Crack in the IPO Window?
Kenneth I. Moch
President and CEO
Chimerix, Inc.

Christian S. Schade
Executive Vice President and CFO
Omthera Pharmaceuticals, Inc.

Panna Sharma
President and CEO
Cancer Genetics, Inc.

Moderator:
Hector G. Calzada, Jr.
Managing Director
Deloitte Corporate Finance LLC

Introduced by:
Stuart Peltz
CEO
PTC Therapeutics, Inc.
2:40 p.m. – 2:55 p.m. Networking Break
2:55 p.m. – 3:10 p.m. Presenting Company
Spiro Rombotis
President and CEO
Cyclacel Pharmaceuticals Inc.

Introduced by:
Oye Olukotun, M.D., MP, FACC, FAHA
Vice Chairman
CardioVax Inc.
3:10 p.m. – 4:10 p.m. Panel – Billion Dollar Babies
Anthony Marucci
Founder, President and CEO
Celldex Therapeutics, Inc.

Francois Nader, M.D.
President and CEO
NPS Pharmaceuticals, Inc.

Glenn Sblendorio
President and CFO
The Medicines Company

Moderator:
Julie Kampf
CEO and President
JBK Associates International

Introduced by:
Christopher Schaber, Ph.D.
President and CEO
Soligenix, Inc.
4:10 p.m. – 4:45 p.m. Afternoon Keynote
Tony Gibney
Managing Director
Leerink Swann LLC

Introduced by:
Marc Bonnefoi, D.V.M., Ph.D.
Head of the North American R&D Hub and Vice President of Disposition, Safety and Animal Research Scientific Core Platform
Sanofi
4:45 p.m. – 5:00 p.m. Closing Remarks

By Invitation Only: BioNJ Board of Trustees, Speakers, Executive Suite Sponsors and Committee of Volunteers

Thursday, October 3, 2013 

6:00 p.m. – 7:00 p.m. Networking Reception
7:00 p.m. – 9:00 p.m. Welcome
Francois Nader, M.D.,
President and CEO,
NPS Pharmaceuticals, Inc.
Fireside Chat
Dominic J. Caruso
Vice President of Finance and CFO
Johnson & Johnson

Introduced by:
Al Altomari
President and CEO
Agile Therapeutics